Escalon Medical Statistics
Total Valuation
Escalon Medical has a market cap or net worth of 1.85 million. The enterprise value is 2.98 million.
| Market Cap | 1.85M |
| Enterprise Value | 2.98M |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Escalon Medical has 7.42 million shares outstanding. The number of shares has decreased by -31.01% in one year.
| Current Share Class | 7.42M |
| Shares Outstanding | 7.42M |
| Shares Change (YoY) | -31.01% |
| Shares Change (QoQ) | +94.51% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | n/a |
| Float | 7.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 1.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.78, with an EV/FCF ratio of -7.56.
| EV / Earnings | -12.47 |
| EV / Sales | 0.24 |
| EV / EBITDA | 40.78 |
| EV / EBIT | n/a |
| EV / FCF | -7.56 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.65 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 11.22 |
| Debt / FCF | -2.08 |
| Interest Coverage | -11.33 |
Financial Efficiency
Return on equity (ROE) is -13.19% and return on invested capital (ROIC) is -5.05%.
| Return on Equity (ROE) | -13.19% |
| Return on Assets (ROA) | -2.64% |
| Return on Invested Capital (ROIC) | -5.05% |
| Return on Capital Employed (ROCE) | -8.40% |
| Weighted Average Cost of Capital (WACC) | 4.56% |
| Revenue Per Employee | 315,667 |
| Profits Per Employee | -6,129 |
| Employee Count | 39 |
| Asset Turnover | 2.60 |
| Inventory Turnover | 4.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.99% in the last 52 weeks. The beta is 0.29, so Escalon Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +36.99% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.22 |
| Relative Strength Index (RSI) | 67.30 |
| Average Volume (20 Days) | 14,101 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, Escalon Medical had revenue of 12.31 million and -239,022 in losses. Loss per share was -0.04.
| Revenue | 12.31M |
| Gross Profit | 5.40M |
| Operating Income | -199,745 |
| Pretax Income | -250,454 |
| Net Income | -239,022 |
| EBITDA | -165,818 |
| EBIT | -199,745 |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 337,434 in cash and 820,081 in debt, with a net cash position of -482,647 or -0.07 per share.
| Cash & Cash Equivalents | 337,434 |
| Total Debt | 820,081 |
| Net Cash | -482,647 |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | 1.77M |
| Book Value Per Share | 0.15 |
| Working Capital | 1.69M |
Cash Flow
In the last 12 months, operating cash flow was -385,952 and capital expenditures -8,301, giving a free cash flow of -394,253.
| Operating Cash Flow | -385,952 |
| Capital Expenditures | -8,301 |
| Free Cash Flow | -394,253 |
| FCF Per Share | -0.05 |
Margins
Gross margin is 43.87%, with operating and profit margins of -1.62% and -2.03%.
| Gross Margin | 43.87% |
| Operating Margin | -1.62% |
| Pretax Margin | -2.03% |
| Profit Margin | -2.03% |
| EBITDA Margin | -1.35% |
| EBIT Margin | -1.62% |
| FCF Margin | n/a |
Dividends & Yields
Escalon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 31.01% |
| Shareholder Yield | 31.01% |
| Earnings Yield | -12.89% |
| FCF Yield | -21.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 24, 1997. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 24, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Escalon Medical has an Altman Z-Score of -16.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.19 |
| Piotroski F-Score | 1 |